Also in 2021, ESCMID will support Study Group research projects in the fields of clinical microbiology and infectious diseases. The call to apply for the ESCMID Study Group Research Grants is officially opened and the deadline for submitting your applications is 23 July 2021, 17:00 CEST.

Make sure to check out the ESCMID YouTube channel, where we are adding some great extra ECCMID content. Catch the Keynote Fireplace sessions, as well as great interviews from ECCMID TV. Be sure to subscribe so you never miss another upload!

An abbreviated information on the 2019/20 changes to the definitions and use of S, I and R has been released by EUCAST for dissemination amongst clinical colleagues who may not be up to date on these new developments. Find out more on the EUCAST website.

Don’t’ miss the next GARDP Webinar! The topic is ‘Discovering and developing new treatments for fungal infections’, with presentations by Tejas Bouklas and Maurizio Del Poeta.

Register on the GARDP website.

ESCMID is pleased to share with you the recent EMA communications on COVID-19 vaccines:

• EMA and ECDC update on COVID-19
• Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis
• EMA advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome
• Vaxzevria: warning for Guillain-Barre syndrome (in PRAC highlights)

Check EMA’s dedicated webpage on COVID-19 for the latest updates.

Delay in diagnosis of tuberculosis (TB) is an important but under-appreciated problem. This study by Zhang et Al. aimed to analyse the patient pathway and possible risk factors of long diagnostic delay (LDD). 400 new bacteriologically diagnosed patients with pulmonary TB were enrolled from 20 hospitals across China. Patients who went to low-level facilities initially had a higher risk of LDD.